Psyence Biomedical Ltd. Common Shares (PBM) — Cash Flow Quality Index

Latest as of December 2022: -0.04x

Psyence Biomedical Ltd. Common Shares (PBM) has a Cash Flow Quality Index of -0.04x as of December 2022. Operating cash flow of $-86.26K is below net income of $2.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Psyence Biomedical Ltd. Common Shares (PBM) long-term investment share to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-0.04x
Operating CF / Net Income

Operating Cash Flow

$-86.26K
USD

Net Income

$2.25 Million
USD

Data as of

Dec 2022
Most recent filing

Psyence Biomedical Ltd. Common Shares Cash Flow Quality Index (2025–2025)

Historical Cash Flow Quality Index for Psyence Biomedical Ltd. Common Shares across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Psyence Biomedical Ltd. Common Shares tangible book value ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Psyence Biomedical Ltd. Common Shares (2025–2025)

Year-by-year earnings quality comparison for Psyence Biomedical Ltd. Common Shares. For live market cap and the full company financial profile, see PBM market cap.

Year Quality Index Operating CF (USD) Net Income YoY Change
2025 -3.69x $-3.73 Million $1.01 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.